<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>ScholarWorks Collection:</title>
  <link rel="alternate" href="https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/319" />
  <subtitle />
  <id>https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/319</id>
  <updated>2026-07-05T10:43:02Z</updated>
  <dc:date>2026-07-05T10:43:02Z</dc:date>
  <entry>
    <title>PHARMACOKINETICS/PHARMACODYNAMICS, SAFETY AND TOLERABILITY OF J2H-1702, A NOVEL 11Β-HSD1 INHIBITOR, AFTER MULTIPLE ORAL ADMINISTRATION</title>
    <link rel="alternate" href="https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/205796" />
    <author>
      <name>이상원</name>
    </author>
    <id>https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/205796</id>
    <updated>2026-07-02T12:00:18Z</updated>
    <published>2024-11-14T00:00:00Z</published>
    <summary type="text">Title: PHARMACOKINETICS/PHARMACODYNAMICS, SAFETY AND TOLERABILITY OF J2H-1702, A NOVEL 11Β-HSD1 INHIBITOR, AFTER MULTIPLE ORAL ADMINISTRATION
Authors: 이상원</summary>
    <dc:date>2024-11-14T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>A DOSE BLOCK-RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, SINGLE-DOSING, DOSE-ESCALATION PHASE 1 CLINICAL TRIAL TO INVESTIGATE THE SAFETY, TOLERABILITY AND PHARMACOKINETIC CHARACTERISTICS OF TB-840 (NONALCOHOLIC STEATOHEPATITIS TREATMENT CANDIDATE) AFTER ORAL ADMINISTRATION IN HEALTHY SUBJECTS</title>
    <link rel="alternate" href="https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/205795" />
    <author>
      <name>이상원</name>
    </author>
    <id>https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/205795</id>
    <updated>2026-07-02T12:00:17Z</updated>
    <published>2024-11-14T00:00:00Z</published>
    <summary type="text">Title: A DOSE BLOCK-RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, SINGLE-DOSING, DOSE-ESCALATION PHASE 1 CLINICAL TRIAL TO INVESTIGATE THE SAFETY, TOLERABILITY AND PHARMACOKINETIC CHARACTERISTICS OF TB-840 (NONALCOHOLIC STEATOHEPATITIS TREATMENT CANDIDATE) AFTER ORAL ADMINISTRATION IN HEALTHY SUBJECTS
Authors: 이상원</summary>
    <dc:date>2024-11-14T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Non-contact Electronic Nose &amp;amp; Future Application Technology</title>
    <link rel="alternate" href="https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/205620" />
    <author>
      <name>장용우</name>
    </author>
    <id>https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/205620</id>
    <updated>2026-07-02T06:35:20Z</updated>
    <published>2024-11-01T00:00:00Z</published>
    <summary type="text">Title: Non-contact Electronic Nose &amp;amp; Future Application Technology
Authors: 장용우</summary>
    <dc:date>2024-11-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Non-Contact Odor Chemical Sensor: Electronic Nose &amp;amp; Future Technology</title>
    <link rel="alternate" href="https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/205619" />
    <author>
      <name>장용우</name>
    </author>
    <id>https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/205619</id>
    <updated>2026-07-02T06:35:19Z</updated>
    <published>2024-10-23T00:00:00Z</published>
    <summary type="text">Title: Non-Contact Odor Chemical Sensor: Electronic Nose &amp;amp; Future Technology
Authors: 장용우</summary>
    <dc:date>2024-10-23T00:00:00Z</dc:date>
  </entry>
</feed>

